Journal of Pharmacology and Experimental Therapeutics 2006-10-01

Differential involvement of Mrp2 (Abcc2) and Bcrp (Abcg2) in biliary excretion of 4-methylumbelliferyl glucuronide and sulfate in the rat.

Maciej J Zamek-Gliszczynski, Keith A Hoffmaster, Joan E Humphreys, Xianbin Tian, Ken-Ichi Nezasa, Kim L R Brouwer

Index: J. Pharmacol. Exp. Ther. 319(1) , 459-67, (2006)

Full Text: HTML

Abstract

The hepatic excretion of hydrophilic conjugates, end products of phase II metabolism, is not completely understood. In the present studies, transport mechanism(s) responsible for the biliary excretion of 4-methylumbelliferyl glucuronide (4MUG) and 4-methylumbelliferyl sulfate (4MUS) were studied. Isolated perfused livers (IPLs) from Mrp2-deficient (TR(-)) Wistar rats were used to examine the role of Mrp2 in the biliary excretion of 4MUG and 4MUS. After a 30-micromol dose of 4-methylumbelliferone, cumulative biliary excretion of 4MUG was extensive in wild-type rat IPLs (25 +/- 3 micromol) but was negligible in TR(-) livers (0.4 +/- 0.1 micromol); coadministration of the Bcrp and P-glycoprotein inhibitor GF120918 [N-(4-[2-(1,2,3,4-tetrahydro-6,7-dimethoxy-2-isoquinolinyl)ethyl]-phenyl)-9,10-dihydro-5-methoxy-9-oxo-4-acridine carboxamide] had no effect on 4MUG biliary excretion in wild-type rat IPLs. In contrast, biliary excretion of 4MUS was partially maintained in Mrp2-deficient rat IPLs. Recovery of 4MUS in bile was approximately 50 to 60% lower in both control TR(-) (149 +/- 8 nmol) and wild-type IPLs with GF120918 coadministration (176 +/- 30 nmol) relative to wild-type control livers (378 +/- 37 nmol) and was nearly abolished in TR(-) IPLs in the presence of GF120918 (13 +/- 8 nmol). These changes were the result of decreased rate constants governing 4MUG and 4MUS biliary excretion. In vitro assays and perfused livers from Bcrp and P-glycoprotein gene-knockout mice indicated that 4MUS did not interact with P-glycoprotein but was transported by Bcrp in a GF120918-sensitive manner. In the rat liver, Mrp2 mediates the biliary excretion of 4MUG, whereas both Mrp2 and Bcrp contribute almost equally to the transport of 4MUS into bile.


Related Compounds

  • 4-Methylumbellifer...
  • 4-Methylumbellifer...

Related Articles:

Development of an enzyme assay for rapid assessment of Escherichia coli in seawaters.

2002-01-01

[J. Appl. Microbiol. 93(4) , 548-56, (2002)]

An alternative approach for enumeration of Escherichia coli in foods.

2001-09-01

[Int. J. Food Microbiol. 68(3) , 217-23, (2001)]

Serogroup distribution and virulence characteristics of sorbitol-negative Escherichia coli from food and cattle stool.

2010-02-01

[J. Appl. Microbiol. 108(2) , 658-65, (2010)]

Differential disposition of intra-renal generated and preformed glucuronides: studies with 4-methylumbelliferone and 4-methylumbelliferyl glucuronide in the filtering and nonfiltering isolated perfused rat kidney.

2011-04-01

[J. Pharm. Pharmacol. 63(4) , 507-14, (2011)]

Evaluation of pharmaceutical excipients as cosolvents in 4-methyl umbelliferone glucuronidation in human liver microsomes: applications for compounds with low solubility.

2011-01-01

[Drug Metab. Pharmacokinet. 26(1) , 102-6, (2011)]

More Articles...